We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Latest news and press releases, information on meetings and events, public consultations and related patient safety information.
How we engage and involve patients and the public in our regulatory decision-making.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The government’s plans for the NHS and social care to deliver for patients, this winter and next.
Work is ongoing to address the comments and feedback from respondents to the consultation. Publication of our report on the consultation has been delayed in light of the Agency’s response during the ongoing coronavirus situation.
An annual publication providing statistics on restricted patients in England and Wales
This document explains: how patients are tested and treated, and steps in place to prevent its spread.
Information for NHS patients and service users.
How to use an ethnographic study to evaluate your digital health product.
Forms and guidance for professionals working with restricted patients (mentally disordered offenders).
A document for patients explaining how the highest risk patient groups eligible for new coronavirus treatments will be identified.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Information and guidance on a range of medical devices for users and patients.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.